PSMA-positron emission tomography/computed tomography (PSMA-PET/CT) has been proven to be effective to diagnose and monitor metastatic PC and CRPC patients and is currently in clinical practice22. The gene discussed is FOLH1; the disease is pachyonychia congenita.